New Regeneron Monoclonal Antibody Treatment Center Now Open in Tropical Park – CBS Miami

JOIN NOW

MIAMI (CBSMiami) — Another state-run monoclonal antibody treatment site has now opened in Southwest Miami-Dade’s Tropical Park.

Governor Ron DeSantis has been touring the state all week announcing the openings of these centers, which use Regeneron to treat patients infected with COVID-19.
Watch Free Movies and TV shows Apps

🎬📺 Free Movies and Free TV Shows! 🎭🎬

READ MORE: Only area of ​​interest in the Eastern Atlantic has low development potential

The other location in South Florida is CB Smith Park in Pembroke Pines.

A Clinic for the Treatment of Regeneron Monoclonal Antibodies in Pembroke Pines. (Eva Marie Uzcategui/Bloomberg via Getty Images)

And like the Broward location, the Miami-Dade treatment center is open seven days a week from 9am-5pm. Each location can treat up to 300 patients per day.

Monoclonal antibodies are man-made proteins that act like human antibodies in the immune system.

The FDA has approved Regeneron for: emergency use as post-exposure prevention for COVID-19 in November. However, the FDA says Regeneron is not a substitute for vaccination against COVID-19 and is still urging all eligible people to get vaccinated.

The treatment gives a temporary, but immediate boost to the immune system, which can reduce the risk of a patient developing serious complications.

READ MORE: More than 100 people march to Domino Park on Calle Ocho to support Cuba’s fight for freedom

It is administered to patients with mild to moderate COVID-19 symptoms in adults and pediatric patients (12 years of age or older) and who are at high risk of progressing to severe COVID-19. This also applies to people 65 years of age or older who have certain chronic medical conditions. High-risk patients include the elderly, immunocompromised, morbidly obese, suffering from heart disease, chronic kidney disease, lung disease and sickle cell disease.

The Regeneron cocktail, if given within 10 days of the first symptoms, are shown to reduce hospitalizations and deaths by about 70% and reduce the risk of infection among a patient’s family members by more than 80%. However, it cannot be used in patients already hospitalized with COVID-19 or undergoing oxygen therapy.

Regeneron is given intravenously or by injection and the treatment is free.

21 treatment locations across the state are expected to be open by next week.

If you qualify for treatment, please visit patientportalfl.com make an appointment.

MORE NEWS: Broward wife Johanna Garcia accused of running Ponzi scheme

More information and a map of other monoclonal antibody sites is available at: floridahealthcovid19.gov. You can also call 850-344-9637.

Leave a Comment